104 related articles for article (PubMed ID: 22298791)
1. What is meant by active disease in the NICE recommendation on use of combination therapy in early RA?
Ezard C; Kumari R; Willott R; Butt S; Gadsby K; Deighton C
Rheumatology (Oxford); 2012 May; 51(5):947-8. PubMed ID: 22298791
[No Abstract] [Full Text] [Related]
2. Recent advances in drug therapy for rheumatoid arthritis.
Malaviya AN; Kaushik P
J Assoc Physicians India; 1999 Sep; 47(9):912-7. PubMed ID: 10778664
[No Abstract] [Full Text] [Related]
3. Is combination second-line therapy in rheumatoid arthritis more aggressive than helpful?
Berthelot JM; Saraux A; Maugars Y; Prost A; Le Goff P
Rev Rhum Engl Ed; 1999 Apr; 66(4):224-8. PubMed ID: 10339779
[No Abstract] [Full Text] [Related]
4. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
5. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
[TBL] [Abstract][Full Text] [Related]
6. Are glucocorticoids DMARDs?
Bijlsma JW; Hoes JN; Van Everdingen AA; Verstappen SM; Jacobs JW
Ann N Y Acad Sci; 2006 Jun; 1069():268-74. PubMed ID: 16855154
[TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoids].
Tanaka H; Hosono O; Kobayashi H; Yoshikawa N; Matsumiya R
Nihon Rinsho; 2013 Jul; 71(7):1261-5. PubMed ID: 23961677
[TBL] [Abstract][Full Text] [Related]
8. Current treatments for rheumatoid arthritis.
Kavanaugh A
Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3 Suppl):4-7. PubMed ID: 17491580
[No Abstract] [Full Text] [Related]
9. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.
Thiele K; Buttgereit F; Huscher D; Zink A;
Arthritis Rheum; 2005 Oct; 53(5):740-7. PubMed ID: 16208641
[TBL] [Abstract][Full Text] [Related]
10. The use of conventional disease-modifying anti-rheumatic drugs in established RA.
Jurgens MS; Jacobs JW; Bijlsma JW
Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):523-33. PubMed ID: 22137922
[TBL] [Abstract][Full Text] [Related]
11. [The goal for the treatment of rheumatoid arthritis should be remission].
Möttönen T; Mäkinen H; Puolakka K
Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
Dougados M; Smolen JS
J Rheumatol Suppl; 2002 Nov; 66():20-6. PubMed ID: 12435165
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF;
Ann Rheum Dis; 2011 Mar; 70(3):469-75. PubMed ID: 21149498
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
Kirwan J; Power L
Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment strategies in early rheumatoid arthritis.
Suresh E; Lambert CM
Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
[TBL] [Abstract][Full Text] [Related]
16. Implementing combination DMARDs strategy in early RA not as nice as we like?
Naseem S
Rheumatol Int; 2013 Dec; 33(12):3071. PubMed ID: 23124735
[No Abstract] [Full Text] [Related]
17. Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy.
Bijlsma JW; van der Goes MC; Hoes JN; Jacobs JW; Buttgereit F; Kirwan J
Ann N Y Acad Sci; 2010 Apr; 1193():123-6. PubMed ID: 20398017
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.
Tak PP; Rigby WF; Rubbert-Roth A; Peterfy CG; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw TM;
Ann Rheum Dis; 2011 Jan; 70(1):39-46. PubMed ID: 20937671
[TBL] [Abstract][Full Text] [Related]
19. Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritis.
Williams HJ
Br J Rheumatol; 1995 Nov; 34 Suppl 2():96-9. PubMed ID: 8535657
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids for rheumatoid arthritis in the era of targeted therapies.
Boers M
Reumatol Clin (Engl Ed); 2019; 15(6):311-314. PubMed ID: 31239208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
